As previous reports of digenic mutations in BBS patients [26] and both BBS2 and BBS9 are parts of a stable multi-protein complex known as the BBSome [27], the pathogenicity of these two variations in BBS9 are questionable and further functional experiments are needed to elucidate the findings. The gene discussed is BBS2; the disease is Bardet-Biedl syndrome.